Targeting GLP-1 receptor trafficking to improve agonist efficacy.

about

Targeting GLP-1 receptor trafficking to improve agonist efficacy.

Item

http://www.wikidata.org/entity/Q53281306

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeting GLP-1 receptor trafficking to improve agonist efficacy.

@en

Targeting GLP-1 receptor trafficking to improve agonist efficacy.

@nl

type

Item

label

Targeting GLP-1 receptor trafficking to improve agonist efficacy.

@en

Targeting GLP-1 receptor trafficking to improve agonist efficacy.

@nl

prefLabel

Targeting GLP-1 receptor trafficking to improve agonist efficacy.

@en

Targeting GLP-1 receptor trafficking to improve agonist efficacy.

@nl

P1476

Targeting GLP-1 receptor trafficking to improve agonist efficacy

@en

P2093

A M James Shapiro

http://www.w3.org/2001/XMLSchema#string

Asuka Inoue

http://www.w3.org/2001/XMLSchema#string

Domenico Bosco

http://www.w3.org/2001/XMLSchema#string

Napat Angkathunyakul

http://www.w3.org/2001/XMLSchema#string

Nisha Kanda

http://www.w3.org/2001/XMLSchema#string

Paul R Johnson

http://www.w3.org/2001/XMLSchema#string

Pauline Chabosseau

http://www.w3.org/2001/XMLSchema#string

Piero Marchetti

http://www.w3.org/2001/XMLSchema#string

Rebecca Scott

http://www.w3.org/2001/XMLSchema#string

Robert Goldin

http://www.w3.org/2001/XMLSchema#string

P2860

Glucagon-like peptide analogues for type 2 diabetes mellitus

Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis

Rab11 regulates recycling through the pericentriolar recycling endosome

Structure-based discovery of opioid analgesics with reduced side effects.

Can residence time offer a useful strategy to target agonist drugs for sustained GPCR responses?

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide

Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes

The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism

Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

P2888

s41467-018-03941-2

P304

1602

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-03941-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29686402

http://www.w3.org/2001/XMLSchema#string

P932

5913239

http://www.w3.org/2001/XMLSchema#string